Tivic Health Systems, Inc. (TIVC)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Jennifer Ernst | Co-Founder, CEO & Director | 317.46k | -- | 1968 |
| Dr. Blake Gurfein Ph.D. | Chief Scientific Officer | 435.67k | -- | 1985 |
| Ms. Lisa G. Wolf | Interim Chief Financial Officer | -- | -- | 1963 |
| Mr. Michael Kevin Handley | COO & President of Tivic Biopharma | -- | -- | 1972 |
Tivic Health Systems, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 7
Description
Tivic Health Systems, Inc. operates as a health tech company, develops and commercializes bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus pain, pressure, and congestion. The company sells its products on online retailers, commercial distributors, and through its own websites; The company's lead product include Entolimod, a biologic program focuses on immunotherapeutics is the late-stage TLR5 agonist for the treatment of acute radiation syndrome. In addition, it markets commercial product under the brand name ClearUP Sinus Pain Relief. It also focusses on non-invasive vagus nerve stimulation. The company was incorporated in 2016 and is based in Fremont, California.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available